# Akorn, Inc. – FDA Warning Letter, May 16, 2018

Source: https://www.keypedia.com/records/warning_letter/akorn-inc/d07fe095-26cd-49a4-a448-3b6512830353

> FDA WARNING_LETTER for Akorn, Inc. on May 16, 2018. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Akorn, Inc.
- Inspection Date: 2018-05-16
- Product Type: Drugs
- Office Name: Detroit District Office
- Summary: The FDA issued a Warning Letter to Akorn, Inc. following an inspection of their Decatur, IL drug manufacturing facility from April 9 to May 16, 2018. The letter identifies significant violations of current good manufacturing practice (CGMP) regulations, rendering their drug products adulterated.

Key violations include:
1.  **Failure to prevent microbiological contamination (21 CFR 211.113(b))**: Observed poor aseptic behavior by operators (e.g., placing heads over open vials, excessive handling of sterile stopper bags, improper wiping), use of non-integral sterile glove and wipe packaging, and inadequate cleanroom design with smoke study deficiencies. The firm's response was deemed insufficient, lacking a comprehensive evaluation of affected batches and commitment to extensive aseptic process redesign.
2.  **Inadequate facility design and control systems (21 CFR 211.42(c)(10))**: Deficiencies in environmental and personnel monitoring programs (e.g., lenient glove CFU limits, sanitizing hands before monitoring), and a deficient cleaning program where operators skipped steps and failed to properly sanitize equipment and surfaces. The firm's responses were inadequate, lacking scientific justification for limits and a thorough investigation into the scope of poor cleaning practices.
3.  **Failure to follow a written stability testing program (21 CFR 211.166(a))**: Inability to ensure stability for acetylcysteine

## Related Documents

- [EIR - 2022-04-08](https://www.keypedia.com/records/eir/akorn-inc/5c8b1b2b-d1b2-4bde-9341-3422919fc9ff) — date: April 8, 2022
- [483 - 2022-04-08](https://www.keypedia.com/records/483/akorn-inc/08076de3-a38f-4fc6-bc2f-28e5d67ef171) — date: April 8, 2022
- [483 - 2018-05-16](https://www.keypedia.com/records/483/akorn-inc/5136e44f-4aca-4b08-9dc5-7fe10577623e) — date: May 16, 2018
- [WARNING_LETTER - 2012-10-02](https://www.keypedia.com/records/warning_letter/akorn-inc/64c1b9d7-84e6-40ae-92cd-c562e847494d) — date: October 2, 2012
- [483 - 2010-09-17](https://www.keypedia.com/records/483/akorn-inc/d583d7c7-6c57-4ec6-8073-4c21483136b9) — date: September 17, 2010

## Related Officers

- [Associate Director](https://www.keypedia.com/people/jeffrey-d-meng/55543677-bd74-4cc5-8a2a-e14afb91d338)
- [Investigator](https://www.keypedia.com/people/russell-k-riley/4813d9c2-52a3-4eba-8606-d4be5e03fd04)

Company: https://www.keypedia.com/companies/akorn-inc/91871042-8cde-411b-b464-09797e0b23db

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03
